MiR-1204 Sensitizes Nasopharyngeal Carcinoma Cells to Paclitaxel Bothin Vitroandin Vivo

Cancer Biology and Therapy - United States
doi 10.1080/15384047.2014.1001287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

HIV Protease Inhibitors Block Akt Signaling and Radiosensitize Tumor Cells BothIn vitroandIn Vivo

Cancer Research
Cancer ResearchOncology
2005English

Cannabinoid Derivatives Exert a Potent Anti-Myeloma Activity Bothin Vitroandin Vivo

International Journal of Cancer
Cancer ResearchOncology
2016English

Osthole Sensitizes With Radiotherapy to Suppress Tumorigenesis of Human Nasopharyngeal Carcinoma in Vitro and in Vivo

Cancer Management and Research
Oncology
2018English

FGF23 Suppresses Chondrocyte Proliferation in the Presence of Soluble Α-Klotho Bothin Vitroandin Vivo

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Loss of NFBD1/MDC1 Disrupts Homologous Recombination Repair and Sensitizes Nasopharyngeal Carcinoma Cells to PARP Inhibitors

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2019English

Emodin Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells to Paclitaxel-Induced Apoptosis in Vitro

Oncology Reports
MedicineCancer ResearchOncology
2009English

miR-135a Contributes to Paclitaxel Resistance in Tumor Cells Both in Vitro and in Vivo

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

MiR-593 Mediates Curcumin-Induced Radiosensitization of Nasopharyngeal Carcinoma Cells via MDR1

Oncology Letters
Cancer ResearchOncology
2016English

The Hsp60-(p.V98I) Mutation Associated With Hereditary Spastic Paraplegia SPG13 Compromises Chaperonin Function Bothin Vitroandin Vivo

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy